In this episode, Libby speaks with Bill Buschle, Global Director - Coatings, Adhesives, Speciality Chemicals and Elastomers (CASE), at Alchemy Cloud.Dive into the future of chemical research and development with Libby and Bill. In this insightful podcast, they unravel the challenges faced by R&D teams, emphasising the critical role of process-focused KPIs over binary output metrics. Explore the impact of legacy software and data silos on innovation, and discover how digital integration and AI tools are reshaping the landscape of chemical R&D. The duo share survey insights, shedding light on industry trends and the exciting role of AI in product development. Join the conversation on overcoming challenges in adopting AI and witness the transformation of R&D into a powerhouse of innovation. Stay tuned for success stories and a deep dive into the evolving role of technology in the ever-changing world of chemicals and advanced materials.To learn more about this topic and the chemicals market at Charlton Morris, drop Libby a message on LinkedIn, here or email at [email protected]. Hosted on Acast. See acast.com/privacy for more information.

In this episode, Emily speaks with Elan Sudberg, CEO of Alkemist Labs and Chair of the American Herbal Products Association's Psychedelic Plants and Fungi Committee.The committee was chartered in 2022 to address issues related to the safe use and responsible commerce of lawfully marketed products derived from psychedelic plants and fungi. Elan Sudberg was appointed as the committee's first chair. Already CEO of a committed testing laboratory specialising in plant authentication, botanical ingredient identification and quantitative analytical services to the food and beverage, nutraceutical and cosmeceutical industries, he was a perfect fit. His passion for supporting the roll-out of produce with powerful natural benefits to the masses really comes across in this chat, and in the work he is doing across both roles.He discusses industry trends, recent acquisitions and their impact on the market, and the tricky business of navigating FDA regulations in this fascinating space. There's plenty to glean from this fascinating discussion, with a really interesting window into the future of the nutraceuticals industry.To learn more about this topic and the wider nutraceuticals market at Charlton Morris, drop Emily a message on LinkedIn, here, or email at [email protected]. Hosted on Acast. See acast.com/privacy for more information.

In this episode, Indre speaks with Carmen Uphoff, COO of Respeggt, a Dutch-German company aiming to bring positive change to the poultry industry by eliminating chick culling.During the conversation, Carmen delves into the technology that allows for gender identification in the hatching egg; preventing the culling of undesired male chicks, a practice that results in the death of about 6 billion chicks worldwide each year.They also touch on the regulatory landscape, noting how Germany and France have already put legislation in place to prevent chick culling, while others are waiting for EU-wide regulations to change, the future of the poultry sector, including the challenges posed by bird flu and the economic crisis. As well as Carmen's insight into a trend leaning towards smaller, more manageable poultry farms as a risk management strategy.For more insights on animal health and welfare, reach out to Indre on LinkedIn or at [email protected]. Hosted on Acast. See acast.com/privacy for more information.

In this episode, Jack speaks with Jacob Glanville and Stephanie Wisner, Co-Founders at Centivax.With a mission to accelerate the world’s transition to post-pathogen humanity, its first broad-spectrum vaccine is currently in pre-clinical development in ferrets and pigs for the prevention of all influenza, awarded the 'Gates Foundation Grand Challenge: End the Pandemic Threat' and featured in hit global Netflix docuseries 'Pandemic: How to Prevent an Outbreak'.This discussion covers a range of topics from the perspective of true entrepreneurs. Including an impressive career history, acquisition story and the insight behind Stephanie's latest foray into writing as the author of 'Building Backwards to BioTech' - an industry-defining project.Sharing stories from inside life as successful co-founders, as well as the journey to acquisition and challenges and learnings along the way. If you're interested in becoming a brilliant biotech entrepreneur or learning about how to become acquired as one, this is the episode for you.To discuss talent solutions, or to tell your own leadership story, reach out to Jack on LinkedIn, or at [email protected]. Hosted on Acast. See acast.com/privacy for more information.

In this episode, Jack speaks with Twlya Tiongson Neal, Managing Director at Accenture. This was a great discussion on commercial strategy and what this looks like in the current life science landscape, the journey into commercial consulting and optimising your business and team for commercial success.Twyla's extraordinary career history, previously heading up teams at IBM and GE Healthcare, makes for an insightful and engaging discussion on commercial growth and strategy. We discuss trends in the market, where she believes the opportunities are, leadership and problem-solving and the importance of communication, amongst other brilliant stories and takeaways.If you're interested in leadership stories, commercial growth strategies or general insights into the future for life science markets, then be sure to have a listen.To discuss talent solutions, or to tell your own leadership story, reach out to Jack on LinkedIn, or at [email protected]. Hosted on Acast. See acast.com/privacy for more information.

The women’s health space is suffering from vast underinvestment. In this live episode, Senior Consultant in this space, Jordan Burgin, is joined by three prominent figures in the field of healthcare and medical technology to discuss 'Changing the Future for Femtech'.Keren Leshem is CEO at OCON Healthcare and a mentor at 80-400 the Health Network. She has been recognised as a World Economic Forum Tech Pioneer for 2022 amongst other impressive achievements.Barry McCann is Founder and CEO of NUA Surgical, bringing a wealth of experience in Surgical Obstetrics and innovation to the panel.Angela Dotson is COO of Alta Science Ltd., an esteemed board member and med-tech angel investor, with a background providing strategic insights to operational strategy for healthcare.Not only are these thought leaders passionate about the future of women's healthcare and its technology, but they campaign for how to overcome barriers and challenges in the industry with some invaluable points during this discussion.The diverse range of perspectives shared during this fascinating chat, including a live Q&A from the audience, is sure to highlight never-before-seen insights into the future of women’s healthcare.To discuss any of the points raised in this discussion in some more detail, get in touch with Jordan on LinkedIn or drop him an email at [email protected]. Hosted on Acast. See acast.com/privacy for more information.

In this episode, Jack speaks with Synda Clements, Director of Talent Acquisition at ConcertAI. This was a great discussion about Talent Strategy and it's importance, using data to inform hiring decisions and key learnings and challenges from her years in the industry.From learning on the job in recruitment to finding her niche in Life Science, Synda has a brilliant and insightful story to tell with plenty of tips for those looking to climb the ladder in talent acquisition. Touching on key topics such as overcoming hiring shortages during economic challenges, how to use marketing in a HR role, and how to forge a path towards a leadership position to meet your goals. As well as plenty of insight into working in the world of AI.If you're interested in talent, leadership stories, or general insights into the world of biotech, then be sure to have a listen.To discuss talent solutions, or to tell your own leadership story, reach out to Jack on LinkedIn, or at [email protected]. Hosted on Acast. See acast.com/privacy for more information.

In this live panel discussion, industry experts Karen Todd, Doug Reader, and Zacharia Levine discuss the importance of gender equity and introducing female-first policies across the nutraceutical industry. Hosted by CM Business Consultant, Emily Austin, a specialist in the nutraceutical space.Karen Todd, CEO of Kyowa Hakka USA and Chair of the Women In Nutraceuticals (WIN) Organisation, shares insight into why gender equity and female-first policies are crucial in the industry right now, as well as identifying gaps in the market that can be addressed to achieve gender equity.Doug Reader, another board member at WIN, joins to discuss the importance of his role in the organisation and the positive change he is conscious must be driven in the industry. Doug shares lessons he has learned throughout his experience as CEO at Arizona Nutritional Supplements (ANS), emphasising the significance of gender diversity boards and their crucial impact on creating better business.Director of People & Sustainability at The Synergy Company, Zacharia Levine, joins later to share his insights on implementing policies which support gender equity and its equal importance for companies across the space - no matter their size. He provides insights into the policies that work and how different businesses can adapt and implement change.For anyone interested in changing perspectives and creating a truly diverse, equity-first and inclusive environment within their business, there are invaluable takeaways here no matter your industry. Listen now, or get in touch with Emily below to discuss this topic in some more detail.For more on talent retention strategies from the team at Charlton Morris, click here, or get in touch with Emily at [email protected] or connect on LinkedIn to chat. Hosted on Acast. See acast.com/privacy for more information.

Corporate development refers to the planning and execution of strategies to meet organisational objectives. The process includes management of team recruitment, phasing in or out of markets or products, arranging strategic alliances, identifying, and acquiring companies (M&A), securing corporate financing, divesting of assets or divisions, and management of intellectual property.In this live webinar, I welcomed two esteemed guests with over 20 years combined experience in corporate development to break down strategies and processes and discuss their insights.Antonio Sanchez-Cordero, a global executive with more than 15 years experience across the healthcare industry and VP of Corporate Development in speciality diagnostics at Thermo Fisher Scientific.Nick Talbot, is an experienced business development strategy lead and Vice President of Corporate Development and Strategy at BD.We covered a range of strategies to identify companies and market opportunities, including importance, alignment, consistency, vision and roadmap, criteria, working with stakeholders and corporate strategy in M&A – which can easily be overlooked.Alongside this, Nick and Antonio covered the structure to build and execute a successful deal, how to successfully integrate a company into a larger organisation during the execution phase, and share their insight in a live audience Q&A at the end of the session too.If you'd like to learn more about the panel or myself, feel free to get in touch via [email protected] or connect with me on LinkedIn to chat.To find out more about CM Life Science, and our full range of talent solutions services, click here or drop me a message today. Hosted on Acast. See acast.com/privacy for more information.

In this episode CM Life Science Business Consultant, Owen Chandler, invites Co-Founder and Chief Lab & Innovation Officer at MySimplePetLab, Dennis Chmiel to chat all things expansion in this ever-growing market.Dennis has an in-depth career history, speaking on behalf of leading innovators in the space, he has always thrown himself into finding future innovations in animal health through harnessing technology. In this episode, Dennis tells us how his mindset fuels opportunities for growth, what he's learned along the way, and what securing Series A funding as a new player in the market means for market expansion in the sector.MySimplePetLab is a tech-enabled pet care company offering both at-home and in-clinic pet testing. It claims to take on the expert nature of effective pet testing, so the customer doesn’t have to. Designed to make pet care testing and results accessible to veterinarians for vets, pets, and pet parents alike. With an aim to keep it simple for both veterinarians and pet owners through a comprehensive offering of vet-approved tests, MySimplePetLab provides the kit, technology, lab, operations, and results to deliver simple pet care for all using an effective data-driven approach.If you'd like to chat some more about the themes in this episode, are keen to feature on a podcast yourself, or want to learn more about CM Life Science's services; then please drop me a message at [email protected] or let's connect on LinkedIn. Hosted on Acast. See acast.com/privacy for more information.